The frequency of EGFR mutations in NSCLC varies according to ethnicity, smoking status, and tumor histology, ranging from 10 to 15% in Western populations to up to 50% in certain Asian cohorts [1,2]. Here, EGFR is linked to non-small cell lung carcinoma.